Mina Nguyen‐Driver
Researcher
Also affiliated: University of Wisconsin–Madison (2017); University of Arizona (2017); Johns Hopkins University (2017); Emory University (2017); Oregon Health & Science University (2013–2022); Cornell University (2017); Pediatrics and Genetics (2013); Technological Assistance Institute for Intellectual Disability (2017)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Mina Nguyen‐Driver's research focuses on phenylketonuria (PKU), a rare genetic disorder. Her work investigates management strategies and neurocognitive outcomes for individuals with PKU, particularly adolescents and young adults who were treated early in life. Nguyen‐Driver has contributed to the development of international consensus recommendations for managing this patient population, utilizing methods such as modified Delphi approaches. She has also explored the link between sustained phenylalanine reduction and improved attention in adults with early-treated PKU. Furthermore, she has been involved in developing a neurocognitive assessment platform designed for use in clinical trials related to PKU. Her scholarship metrics include an h-index of 9, with 13 total publications and 307 citations.
Metrics
- h-index: 9
- Publications: 13
- Citations: 312
Selected Publications
-
Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup (2024)
Collaboration Network
Top Collaborators
- Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup
- Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup
- Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup
- Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup
- Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup
- Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup
- Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup
- Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup
- Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup
- Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup
- Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup
- Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup
- Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup
- Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup
- Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup
Similar Researchers
Based on overlapping research topics